QIU, Yaqi
 Distribuzione geografica
Continente #
EU - Europa 153
NA - Nord America 98
AS - Asia 47
SA - Sud America 4
AF - Africa 1
OC - Oceania 1
Totale 304
Nazione #
US - Stati Uniti d'America 91
IT - Italia 81
CN - Cina 18
FR - Francia 16
GB - Regno Unito 12
CZ - Repubblica Ceca 8
DE - Germania 8
RU - Federazione Russa 8
JP - Giappone 7
NL - Olanda 6
CA - Canada 5
HK - Hong Kong 5
DK - Danimarca 4
SG - Singapore 4
BR - Brasile 3
TW - Taiwan 3
VN - Vietnam 3
CH - Svizzera 2
FI - Finlandia 2
KR - Corea 2
MX - Messico 2
PH - Filippine 2
SE - Svezia 2
UA - Ucraina 2
AU - Australia 1
CL - Cile 1
GH - Ghana 1
IE - Irlanda 1
IN - India 1
IR - Iran 1
RO - Romania 1
YE - Yemen 1
Totale 304
Città #
Milan 23
Torino 16
Turin 10
Santa Cruz 8
Fairfield 7
Shanghai 5
Ashburn 4
Paris 4
Seattle 4
Amsterdam 3
Chicago 3
Cinisello Balsamo 3
Copenhagen 3
São Paulo 3
Bristol 2
Cambridge 2
Central 2
Columbus 2
Dallas 2
Ellicott City 2
Glasgow 2
Guangzhou 2
Hirakata 2
Kowloon 2
Lake Forest 2
Lappeenranta 2
Lausanne 2
New York 2
Rome 2
San Diego 2
San Jose 2
Santa Clara 2
Tokyo 2
Wilmington 2
Woodbridge 2
Wuhan 2
Yongin-si 2
Adelfia 1
Alessandria 1
Amasaman 1
Ann Arbor 1
Atlanta 1
Bartensleben 1
Boardman 1
Buffalo 1
Cebu City 1
Charlottesville 1
Cho Ha 1
Chongqing 1
Cincinnati 1
Council Bluffs 1
Cuernavaca 1
Dong Ket 1
Dublin 1
Düsseldorf 1
Exeter 1
Frederikshavn 1
Gunzenhausen 1
Houssen 1
Houston 1
Huddinge 1
Iasi 1
Kashan 1
Lincoln 1
Los Angeles 1
Luni 1
Madison 1
Mazzè 1
Messina 1
Moncalieri 1
Mondovì 1
Neef 1
New Taipei City 1
North East 1
Omaha 1
Orangeville 1
Ottawa 1
Piacenza 1
Pisa 1
Pittsburgh 1
Portland 1
Prague 1
Provo 1
Quezon City 1
Redmond 1
Rotterdam 1
San Francisco 1
San Mauro Torinese 1
Sanaa 1
Santiago 1
Shenyang 1
Silver Spring 1
Singapore 1
Spokane 1
Stony Brook 1
Suita 1
Surat 1
Taipei 1
The Bronx 1
Toronto 1
Totale 205
Nome #
A rationally designed NRP1-independent superagonist SEMA3A mutant is an effective anticancer agent, file e27ce42d-6655-2581-e053-d805fe0acbaa 136
HIV-protease inhibitors block HPV16-induced murine cervical carcinoma and promote vessel normalization in association with MMP-9 inhibition and TIMP-3 induction, file e27ce431-ed1e-2581-e053-d805fe0acbaa 74
Semaphorin 4A-expressing bone marrowderived myeloid cells promote tumor progression, file fa14c902-131c-4603-a4d2-23ed97a4cad4 30
Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5- a]pyridine Scaffold: SAR of the Biphenyl Moiety, file e27ce432-fd74-2581-e053-d805fe0acbaa 23
Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5- a]pyridine Scaffold: SAR of the Biphenyl Moiety, file e27ce432-bb56-2581-e053-d805fe0acbaa 20
Semaphorin 4A-expressing bone marrowderived myeloid cells promote tumor progression, file 8d5c83bc-ca94-462b-bcbb-0bda8b642def 18
Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5- a]pyridine Scaffold: SAR of the Biphenyl Moiety, file e27ce432-bcf1-2581-e053-d805fe0acbaa 5
A rationally designed NRP1-independent superagonist SEMA3A mutant is an effective anticancer agent, file e27ce42d-736a-2581-e053-d805fe0acbaa 3
A rationally designed NRP1-independent superagonist SEMA3A mutant is an effective anticancer agent, file e27ce432-515e-2581-e053-d805fe0acbaa 2
Totale 311
Categoria #
all - tutte 803
article - articoli 0
book - libri 0
conference - conferenze 201
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.004


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20194 0 0 0 0 0 0 0 0 0 0 0 4
2019/202015 6 2 1 0 0 0 1 0 2 1 1 1
2020/202151 2 1 0 5 4 1 3 6 5 7 5 12
2021/202269 3 1 1 14 4 3 11 9 1 3 9 10
2022/2023103 4 9 13 18 10 9 12 4 7 11 5 1
2023/202463 1 10 2 4 2 1 4 10 0 3 23 3
Totale 311